Your browser doesn't support javascript.
loading
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
Arriola, Edurne; Wheater, Matthew; Galea, Ian; Cross, Nadia; Maishman, Tom; Hamid, Debbie; Stanton, Louise; Cave, Judith; Geldart, Tom; Mulatero, Clive; Potter, Vannessa; Danson, Sarah; Woll, Pennella J; Griffiths, Richard; Nolan, Luke; Ottensmeier, Christian.
Afiliação
  • Arriola E; University of Southampton, Southampton, United Kingdom. Electronic address: e.arriola-aperribay@soton.ac.uk.
  • Wheater M; University Hospital Southampton, Southampton, United Kingdom.
  • Galea I; Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Cross N; Southampton Clinical Trials Unit, University of Southampton, United Kingdom.
  • Maishman T; Southampton Clinical Trials Unit, University of Southampton, United Kingdom.
  • Hamid D; Southampton Clinical Trials Unit, University of Southampton, United Kingdom.
  • Stanton L; Southampton Clinical Trials Unit, University of Southampton, United Kingdom.
  • Cave J; University Hospital Southampton, Southampton, United Kingdom.
  • Geldart T; Royal Bournemouth and Christchurch Hospitals National Health Service Trust, Bournemouth, United Kingdom.
  • Mulatero C; St. James's University Hospital, Leeds, United Kingdom.
  • Potter V; Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
  • Danson S; Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, United Kingdom.
  • Woll PJ; Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, United Kingdom.
  • Griffiths R; The Clatterbridge Cancer Centre National Health Service Foundation Trust, Wirral, United Kingdom.
  • Nolan L; University Hospital Southampton, Southampton, United Kingdom.
  • Ottensmeier C; University of Southampton, Southampton, United Kingdom.
J Thorac Oncol ; 11(9): 1511-21, 2016 09.
Article em En | MEDLINE | ID: mdl-27296105
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article